Keita Tatsuno

Keita Tatsuno

Auto-generated profile, based on publicly available information

Keita Tatsuno

Department of Infection Control and Prevention, Mitsui Memorial Hospital, Tokyo 101-8643, Japan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2019 in Infectious Diseases and Therapy
Verified
Journal Article
Open access
PDF file
KTKeita Tatsuno
Keita Tatsuno
MIMahoko Ikeda
Mahoko Ikeda
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
SYShintaro Yanagimoto
Shintaro Yanagimoto
SOShu Okugawa
Shu Okugawa
KMKyoji Moriya
Kyoji Moriya
Introduction This study aimed to compare the clinical characteristics and prognoses of central venous catheter-associated bloodstream infections (CVC-BSIs) with peripheral venous catheter-associated BSIs (PVC-BSIs). Methods This retrospective observational study was conducted between April 2011 and March 2013 at a teaching hospital in Tokyo, Japan. Adult patients who developed CVC-BSIs and PVC-BSIs more than 2 days after admission were included. Patients with both CVC-BSIs and PVC-BSIs were excluded. Clinical characteristics of patients with CVC-BSIs and PVC-BSIs were obtained from medical records, and 30-day all-cause mortality was measured as the clinical outcome. Results We enrolled 124 PVC-BSI cases and 110 CVC-BSI cases. Median age, age-adjusted Charlson score, Sequential Organ Failure Assessment score, sex, and ward type at BSI onset did not differ significantly between the two groups. The median duration of catheter indwelling was significantly shorter in the PVC-BSI group than in the CVC-BSI group. Staphylococcus aureus and Gram-negative bacilli infections were more frequent and coagulase-negative staphylococci (CNS) and Candida spp. infections were less frequent in the PVC-BSI group than in the CVC-BSI group. The prevalence of oxacillin resistance among causative S. aureus and CNS, 30-day all-cause mortality, and appropriateness of empirical and definitive antimicrobial therapies did not differ significantly between the two groups. Conclusion The pathogen species distribution varies between PVC-BSIs and CVC-BSIs. However, all-cause mortality does not differ between the two groups. PVCs are not safer than CVCs with respect to BSIs; therefore, it is necessary to use similar precautions relevant to CVC use in order to avoid unnecessary use of PVCs.

18 May 2013 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
TTTakashi Toya
Takashi Toya
ASAkihito Shinohara
Akihito Shinohara
KTKeita Tatsuno
Keita Tatsuno
SSSachiko Seo
Sachiko Seo
YNYasuhito Nannya
Yasuhito Nannya
MKMineo Kurokawa
Mineo Kurokawa

1 February 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SYShintaro YANAGIMOTO
Shintaro YANAGIMOTO
KTKeita Tatsuno
Keita Tatsuno
SOShu Okugawa
Shu Okugawa
TKTakatoshi Kitazawa
Takatoshi Kitazawa
KTKunihisa Tsukada
Kunihisa Tsukada
YOYasuo Ota
Yasuo Ota
Toll-like receptor 4 (TLR4) is essential for recognizing a Gram-negative bacterial component, lipopolysaccharide (LPS). A single amino acid mutation at position 712 of murine TLR4 leads to hyporesponsiveness to LPS. In this study we determined that an amino acid, a leucine at position 815 of human TLR4, is also pivotal for LPS responsiveness and subcellular distribution. By replacing the leucine with alanine, the mutant TLR4 lost responsiveness to LPS and did not localize on the plasma membrane. In addition, it does not coprecipitate with myeloid differentiation-2, an accessory protein that is necessary for TLR4 to recognize LPS. These results suggest that the leucine at position 815 is required for the normal maturation of TLR4 and for formation of the TLR4·MD-2 complex.

19 December 2019 in Access Microbiology
Verified
Journal Article
Open access
YOYuta Okada
Yuta Okada
YYYuka Yagihara
Yuka Yagihara
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
GIGene Igawa
Gene Igawa
RSRyoichi Saito
Ryoichi Saito
KMKyoji Moriya
Kyoji Moriya
Introduction. Clostridioides difficile is one of the most important nosocomial pathogens; however, reports regarding its clinical and molecular characteristics from Japan are scarce. Aims. We studied the multilocus sequence typing (MLST)-based epidemiology and virulence-associated genes of isolates and the clinical backgrounds of patients from whom the isolates had been recovered. Methods. A total of 105 stool samples tested in a C. difficile toxin enzyme immune assay (EIA) were analysed at the University of Tokyo Hospital from March 2013 to July 2014. PCR for MLST and the virulence-associated genes tcdA, tcdB, cdtA, cdtB and tcdC was performed on C. difficile isolates meeting our inclusion criteria following retrospective review of medical records. EIA-positive and EIA-negative groups with toxigenic strains underwent clinical and molecular background comparison. Results. The toxigenic strains ST17, ST81, ST2, ST54, ST8, ST3, ST37 and ST53 and the non-toxigenic strains ST109, ST15 and ST100 were frequently recovered. The prevalence rate of tcdA-negative ST81 and ST37, endemic in China and Korea, was higher (11.4%) than that reported in North America and Europe, and hypervirulent ST1(RT027) and ST11(RT078) strains that occur in North America and Europe were not recovered. The linkage between the EIA results and cdt A/B positivity, tcdC deletion, or tcdA variation was absent among toxigenic strains. Compared with the 38 EIA-negative cases, the 36 EIA-positive cases showed that the patients in EIA-positive cases were older and more frequently had chronic kidney disease, as well as a history of beta-lactam use and proton pump inhibitor therapy. Conclusion. In Japan, the prevalence rates for tcdA-negative strains are high, whereas the cdtA/B-positive strains are rare. EIA positivity is linked to older age, chronic kidney disease and the use of beta-lactams and proton pump inhibitors.

1 February 2018 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SYShinya Yamamoto
Shinya Yamamoto
MIMahoko Ikeda
Mahoko Ikeda
FFFumie Fujimoto
Fumie Fujimoto
KOKoh Okamoto
Koh Okamoto
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
KMKyoji Moriya
Kyoji Moriya

3 January 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
Takashi AzumaTakashi Azuma
Takashi Azuma
ATAi Tsukada
Ai Tsukada
NFNaoki Fujii
Naoki Fujii
MKMiwa Katagiri
Miwa Katagiri
INItaru Nakamura
Itaru Nakamura
NMNobuaki Matsunaga
Nobuaki Matsunaga
Background: Hospitals are recognized as point sources of antimicrobials in urban wastewater systems; however, comprehensive evaluations of their discharge profiles have not yet been conducted. Methods: This study presents a multi-site investigation of residual antimicrobial concentrations in effluents from five general hospitals and a commercial facility in the metropolitan area of Japan. Over a 12-week period (December 2023–March 2024), extensive sampling was conducted. Fifteen antimicrobials from multiple classes were quantified using high-throughput analysis. Results: The results revealed consistently higher concentrations in hospital effluents, particularly for levofloxacin, vancomycin, and ampicillin, than in non-clinical sites. Distinct facility-specific and temporal patterns suggest strong links between local prescribing practices and the effluent composition. Some compounds, such as clarithromycin and minocycline, showed dual contributions from both hospital and commercial sources. Conclusions: These findings highlight the need for source-targeted monitoring and antimicrobial pollution control strategies and provide a foundation for expanding surveillance efforts and informing environmental policies related to antimicrobial resistance (AMR).